{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:05:06Z","timestamp":1747170306315,"version":"3.40.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":239,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.rmcr.2024.102101","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T02:21:41Z","timestamp":1724898101000},"page":"102101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Camrelizumab combined with chemotherapy for stage IV pulmonary sarcomatoid cancer with pancreatic metastases"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3916-5809","authenticated-orcid":false,"given":"Liqin","family":"Ruan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningbo","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weili","family":"chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"xiaoyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin hua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rmcr.2024.102101_bib1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cllc.2016.11.016","article-title":"Pulmonary sarcomatoid carcinoma: an analysis of the national cancer data base","volume":"18","author":"Steuer","year":"2017","journal-title":"Clin. Lung Cancer"},{"issue":"12","key":"10.1016\/j.rmcr.2024.102101_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/01.JTO.0000437008.00554.90","article-title":"Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma","volume":"8","author":"Vieira","year":"2013","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.rmcr.2024.102101_bib3","doi-asserted-by":"crossref","DOI":"10.4103\/lungindia.lungindia_525_19","article-title":"Prognostic factors for sarcomatoid carcinomas of lung: a single-centre experience","volume":"37","author":"Sayan","year":"2020","journal-title":"Lung India"},{"issue":"5","key":"10.1016\/j.rmcr.2024.102101_bib4","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.jtcvs.2021.01.081","article-title":"Adjuvant chemotherapy for pulmonary sarcomatoid carcinoma: a retrospective analysis of the National Cancer Database","volume":"163","author":"Abdallah","year":"2022","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.rmcr.2024.102101_bib5","article-title":"Cancer: epidemiology of lung cancer","volume":"vols. 1\u20134","author":"Alberg","year":"2023"},{"issue":"14","key":"10.1016\/j.rmcr.2024.102101_bib6","doi-asserted-by":"crossref","DOI":"10.7150\/jca.30463","article-title":"Prognostic value of site-specific metastases in lung cancer: a population based study","volume":"10","author":"Li","year":"2019","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.rmcr.2024.102101_bib7","doi-asserted-by":"crossref","DOI":"10.3892\/mco.2014.410","article-title":"Specific organ metastases and survival in metastatic non-small-cell lung cancer","volume":"3","author":"Tamura","year":"2015","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"10.1016\/j.rmcr.2024.102101_bib8","article-title":"A retrospective study of 42 lung cancer patients with pancreatic metastases","volume":"22","author":"Zhang","year":"2019","journal-title":"Chin. J. Lung Cancer"},{"issue":"1","key":"10.1016\/j.rmcr.2024.102101_bib9","doi-asserted-by":"crossref","DOI":"10.1159\/000497387","article-title":"A rare pancreatic tail metastasis from squamous cell lung carcinoma diagnosed by EUS-FNB and a small review of the literature","volume":"27","author":"Stoupis","year":"2020","journal-title":"GE Port. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.rmcr.2024.102101_bib10","article-title":"A resected case of pancreatic cancer diagnosed by EUS-FNA, which was useful in differentiation from pancreatic metastasis from lung cancer","volume":"56","author":"Hiramatsu","year":"2014","journal-title":"Gastroenterol. Endosc."},{"issue":"1","key":"10.1016\/j.rmcr.2024.102101_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/s12149-008-0205-5","article-title":"Usefulness of FDG-PET\/CT in the detection of pancreatic metastases from lung cancer","volume":"23","author":"Sato","year":"2009","journal-title":"Ann. Nucl. Med."},{"issue":"5","key":"10.1016\/j.rmcr.2024.102101_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000002986","article-title":"Isolated pancreatic metastasis from squamous cell lung cancer mimicking primary pancreatic ductal adenocarcinoma on FDG PET\/CT","volume":"45","author":"Zhou","year":"2020","journal-title":"Clin. Nucl. Med."},{"issue":"8","key":"10.1016\/j.rmcr.2024.102101_bib13","article-title":"Clinical characteristics of lung cancer with pancreatic metastases","volume":"20","author":"Duan","year":"2017","journal-title":"Chin. J. Lung Cancer"},{"issue":"2","key":"10.1016\/j.rmcr.2024.102101_bib14","article-title":"Obstructive jaundice in small cell lung carcinoma","volume":"37","author":"Mokhtar Pour","year":"2015","journal-title":"Malays. J. Pathol."},{"issue":"5","key":"10.1016\/j.rmcr.2024.102101_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.36347\/sjmcr.2022.v10i05.004","article-title":"Pancreatic metastasis of lung cancer: a case report","volume":"10","author":"Idrissi","year":"2022","journal-title":"Scholars J. Med. Case Rep."},{"issue":"5","key":"10.1016\/j.rmcr.2024.102101_bib16","article-title":"Metastasis-induced acute pancreatitis in a patient with small cell carcinoma of the lungs","volume":"10","author":"Tanaka","year":"2009","journal-title":"J. Pancreas"},{"issue":"4","key":"10.1016\/j.rmcr.2024.102101_bib17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12328-019-00944-4","article-title":"Obstructive pancreatitis secondary to a pancreatic metastasis from lung cancer treated with nasopancreatic drainage","volume":"12","author":"Kawaguchi","year":"2019","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.rmcr.2024.102101_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2019.07.060","article-title":"A long-term survival case after resection of the pancreatic metastasis from lung cancer","volume":"61","author":"Kageyama","year":"2019","journal-title":"Int J Surg Case Rep"},{"issue":"1","key":"10.1016\/j.rmcr.2024.102101_bib19","article-title":"A surgical case of pancreatic metastasis from lung cancer","volume":"105","author":"Suzumura","year":"2021","journal-title":"Int. Surg."},{"year":"2015","series-title":"Systemic Therapy for Stage IV Non-small-cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","author":"Masters","key":"10.1016\/j.rmcr.2024.102101_bib20"},{"issue":"1","key":"10.1016\/j.rmcr.2024.102101_bib21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1186\/s12885-020-07690-8","article-title":"Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)","volume":"20","author":"Brueckl","year":"2020","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.rmcr.2024.102101_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/JTO.0b013e318292be18","article-title":"Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1)","volume":"8","author":"Velcheti","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.rmcr.2024.102101_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2016.05.013","article-title":"Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages","volume":"98","author":"Vieira","year":"2016","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.rmcr.2024.102101_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2020.02.022","article-title":"Relationship between programmed death receptor-ligand 1 expression and response to checkpoint inhibitor immunotherapy in pulmonary sarcomatoid carcinoma: a pooled analysis","volume":"21","author":"Babacan","year":"2020","journal-title":"Clin. Lung Cancer"},{"issue":"5","key":"10.1016\/j.rmcr.2024.102101_bib25","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jtho.2020.01.014","article-title":"Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma","volume":"15","author":"Domblides","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"Sep","key":"10.1016\/j.rmcr.2024.102101_bib26","article-title":"Corrigendum: the efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma","volume":"14","author":"Zeng","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.rmcr.2024.102101_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s10147-019-01454-6","article-title":"Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas","volume":"24","author":"Liang","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.rmcr.2024.102101_bib28","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-16-2554","article-title":"Potential predictive value of TP53 and KRAS mutation status for response to PD-1 blockade immunotherapy in lung adenocarcinoma","volume":"23","author":"Dong","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.rmcr.2024.102101_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2017.10.017","article-title":"Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: comparison of RECIST 1.1, irRECIST and iRECIST criteria","volume":"88","author":"Tazdait","year":"2018","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.rmcr.2024.102101_bib30","article-title":"Dissociated response and clinical benefit in patients treated with nivolumab monotherapy","volume":"39","author":"Sato","year":"2021","journal-title":"Invest. N. Drugs"},{"issue":"11","key":"10.1016\/j.rmcr.2024.102101_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-020-03282-y","article-title":"Overall survival benefit of continuing immune checkpoint inhibitors treatment post dissociated response in patients with advanced lung cancer","volume":"146","author":"Zhou","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.rmcr.2024.102101_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-019-04573-4","article-title":"18FDG PET\/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns","volume":"47","author":"Humbert","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"1","key":"10.1016\/j.rmcr.2024.102101_bib33","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-020-02647-z","article-title":"Patterns of progression in patients treated for immuno-oncology antibodies combination","volume":"70","author":"Bernard-Tessier","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"year":"2022","series-title":"Immune-related Dissociated Response as a Specific Atypical Response Pattern in Solid Tumors with Immune Checkpoint Blockade","author":"Guan","key":"10.1016\/j.rmcr.2024.102101_bib34"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007124001242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007124001242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T05:07:36Z","timestamp":1726636056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007124001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":34,"alternative-id":["S2213007124001242"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2024.102101","relation":{},"ISSN":["2213-0071"],"issn-type":[{"type":"print","value":"2213-0071"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Camrelizumab combined with chemotherapy for stage IV pulmonary sarcomatoid cancer with pancreatic metastases","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2024.102101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102101"}}